Mok T - Search Results

1

Tumor p16M is a possible marker of advanced stage in non-small cell lung cancer.

Ng CS, Zhang J, Wan S, Lee TW, Arifi AA, Mok T, Lo DY, Yim AP. Ng CS, et al. Among authors: mok t. J Surg Oncol. 2002 Feb;79(2):101-6. doi: 10.1002/jso.10046. J Surg Oncol. 2002. PMID: 11815997

2

Multimodality treatment of primary lymphoepithelioma-like carcinoma of the lung.

Chan AT, Teo PM, Lam KC, Chan WY, Chow JH, Yim AP, Mok TS, Kwan WH, Leung TW, Johnson PJ. Chan AT, et al. Among authors: mok ts. Cancer. 1998 Sep 1;83(5):925-9. doi: 10.1002/(sici)1097-0142(19980901)83:5<925::aid-cncr18>3.0.co;2-x. Cancer. 1998. PMID: 9731896 Clinical Trial.

3

Lack of expression for the suppressor PML in human small cell lung carcinoma.

Zhang P, Chin W, Chow LT, Chan AS, Yim AP, Leung SF, Mok TS, Chang KS, Johnson PJ, Chan JY. Zhang P, et al. Among authors: mok ts. Int J Cancer. 2000 Mar 1;85(5):599-605. doi: 10.1002/(sici)1097-0215(20000301)85:5<599::aid-ijc1>3.0.co;2-#. Int J Cancer. 2000. PMID: 10699936

4

A phase II study of gemcitabine plus oral etoposide in the treatment of patients with advanced nonsmall cell lung carcinoma.

Mok TS, Zee B, Chan AT, Yeo W, Yang WT, Yim A, Leung SF, Nguyen B, Leung TW, Johnson P. Mok TS, et al. Cancer. 2000 Aug 1;89(3):543-50. Cancer. 2000. PMID: 10931453 Clinical Trial.

5

Application of classification tree and neural network algorithms to the identification of serological liver marker profiles for the diagnosis of hepatocellular carcinoma.

Poon TC, Chan AT, Zee B, Ho SK, Mok TS, Leung TW, Johnson PJ. Poon TC, et al. Among authors: mok ts. Oncology. 2001;61(4):275-83. doi: 10.1159/000055334. Oncology. 2001. PMID: 11721174

6

Efficacy and safety of erlotinib in 1242 East/South-East Asian patients with advanced non-small cell lung cancer.

Mok T, Wu YL, Au JS, Zhou C, Zhang L, Perng RP, Park K. Mok T, et al. J Thorac Oncol. 2010 Oct;5(10):1609-15. doi: 10.1097/JTO.0b013e3181e15d55. J Thorac Oncol. 2010. PMID: 20808255 Free article. Clinical Trial.

7

Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer.

Kerr KM, Bubendorf L, Edelman MJ, Marchetti A, Mok T, Novello S, O'Byrne K, Stahel R, Peters S, Felip E; Panel Members. Kerr KM, et al. Among authors: mok t. Ann Oncol. 2014 Sep;25(9):1681-1690. doi: 10.1093/annonc/mdu145. Epub 2014 Apr 8. Ann Oncol. 2014. PMID: 24718890 Free article.

8

Dacomitinib for the treatment of advanced or metastatic non-small-cell lung cancer.

Mok T, Lee K, Tang M, Leung L. Mok T, et al. Future Oncol. 2014 Apr;10(5):813-22. doi: 10.2217/fon.14.22. Future Oncol. 2014. PMID: 24799062

9

A correlative biomarker analysis of the combination of bevacizumab and carboplatin-based chemotherapy for advanced nonsquamous non-small-cell lung cancer: results of the phase II randomized ABIGAIL study (BO21015).

Mok T, Gorbunova V, Juhasz E, Szima B, Burdaeva O, Orlov S, Yu CJ, Archer V, Hilton M, Delmar P, Pallaud C, Reck M. Mok T, et al. J Thorac Oncol. 2014 Jun;9(6):848-55. doi: 10.1097/JTO.0000000000000160. J Thorac Oncol. 2014. PMID: 24807156 Free article. Clinical Trial.

10

Randomized phase II study of two intercalated combinations of eribulin mesylate and erlotinib in patients with previously treated advanced non-small-cell lung cancer.

Mok TS, Geater SL, Iannotti N, Thongprasert S, Spira A, Smith D, Lee V, Lim WT, Reyderman L, Wang B, Gopalakrishna P, Garzon F, Xu L, Reynolds C. Mok TS, et al. Ann Oncol. 2014 Aug;25(8):1578-84. doi: 10.1093/annonc/mdu174. Epub 2014 May 14. Ann Oncol. 2014. PMID: 24827127 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

608 results

Search Page

Filters